JCO:有望改写指南!北京大学肿瘤医院团队在食管鳞癌治疗上取得突破( 三 )


6.HuangJ,XuJ,ChenY,ZhuangW,ZhangY,ChenZ,ChenJ,ZhangH,NiuZ,FanQetal:Camrelizumabversusinvestigator'schoiceofchemotherapyassecond-linetherapyforadvancedormetastaticoesophagealsquamouscellcarcinoma(ESCORT):amulticentre,randomised,open-label,phase3study.LancetOncol2020,21(6):832-842.
7.WangZX,CuiC,YaoJ,ZhangY,LiM,FengJ,YangS,FanY,ShiJ,ZhangXetal:Toripalimabpluschemotherapyintreatment-naive,advancedesophagealsquamouscellcarcinoma(JUPITER-06):Amulti-centerphase3trial.CancerCell2022,40(3):277-288e273.
8.ShenL,KatoK,KimSB,AjaniJA,ZhaoK,HeZ,YuX,ShuY,LuoQ,WangJetal:TislelizumabVersusChemotherapyasSecond-LineTreatmentforAdvancedorMetastaticEsophagealSquamousCellCarcinoma(RATIONALE-302):ARandomizedPhaseIIIStudy.JClinOncol2022:JCO2101926.
责任编辑丨BioTalker